Cannabis use, unspecified with intoxication, unspecified
ICD-10 F12.929 is a billable code used to indicate a diagnosis of cannabis use, unspecified with intoxication, unspecified.
F12.929 refers to a diagnosis of cannabis use disorder characterized by the consumption of cannabis leading to intoxication, but without specific details regarding the severity or duration of use. Cannabis use disorder can manifest as a problematic pattern of cannabis use leading to clinically significant impairment or distress. Symptoms may include increased tolerance, withdrawal symptoms, and continued use despite negative consequences. Intoxication can present with symptoms such as euphoria, altered perception, impaired coordination, and anxiety. The unspecified nature of this code indicates that the clinician has not provided specific details about the frequency or quantity of cannabis use, making it essential for coders to ensure that documentation supports the diagnosis. Treatment options may include behavioral therapies, counseling, and support groups, focusing on reducing use and managing withdrawal symptoms. Accurate coding is crucial for appropriate treatment planning and insurance reimbursement.
Detailed patient history, including substance use patterns and treatment history.
Patients presenting with withdrawal symptoms or seeking treatment for cannabis use.
Consideration of co-occurring mental health disorders and their impact on treatment.
Comprehensive mental health evaluation and documentation of any psychiatric symptoms related to cannabis use.
Patients experiencing anxiety or mood disorders exacerbated by cannabis use.
Assessment of the patient's overall mental health status and any potential need for dual diagnosis treatment.
Used when counseling for cannabis cessation is provided.
Document the time spent in counseling and the patient's response.
Addiction specialists may need to provide more detailed documentation.
F12.929 is used for unspecified cannabis use with intoxication, while F12.20 is for cannabis dependence, which requires more specific documentation of the patient's use patterns and symptoms.
